FDA approves Linzess (Linaclotide) for kids 7+ with IBS-C: First-ever treatment for pediatric constipation pain
The FDA has approved Linzess (linaclotide) for children aged 7 and older with IBS-C, marking the first FDA-approved drug for this condition in younger patients. This medication helps improve bowel movement frequency and reduce abdominal pain, offering a safe and effective treatment option for children struggling with chronic constipation and discomfort.
Most Recent